Michigan Medicine 15th Annual Advanced Liver Disease and Liver Transplantation Update

The University of Michigan Transplant Center is pleased to offer our 15th Annual Advanced Liver Disease and Liver Transplantation Update as a live webinar.

Description

• Include: 8 videos + 1 pdf, size: 1.02 GB
• Target Audience: gastroenterologist, primary care physican

Information:

Description

The University of Michigan Transplant Center is pleased to offer our 15th Annual Advanced Liver Disease and Liver Transplantation Update as a live webinar. This course is to provide an update on recent developments in the management of patients with advanced liver disease including recent shifts in the etiology of liver failure, medical management of alcoholic liver disease, and the prevention and treatment of COVID-19 in patients with liver disease.

In addition, updates on the evolving use of living donor liver transplantation for adults and children with liver failure will be reviewed along with developments of biomarkers and protocols to achieve immunological tolerance in long-term liver transplant recipients. This year’s course will be on Friday, April 23 from 8:00 a.m. to 12:30 p.m. The webinar link will be provided to registered attendees prior to the date of the program.

Target Audience

This activity is appropriate for:

House Officers, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers

In the fields of:

Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery

Learning Objectives

At the end of this activity, participant should be able to:

1. 1. Use temporal trends in indications for liver transplantation including the increasing proportion of patients with alcoholic liver disease
   2. Utilize available resources and strategies to identify and treat patients with alcohol use disorder
   3. Know how vaccination and antiviral/ immunomodulatory approaches work for patients with COVID-19 infectionExpand knowledge of the evolving safety
   4. and efficacy of adult living donor liver transplantation
   5. Rely on information provided by new developments regarding serum biomarkers of immunological tolerance and strategies to safely minimize long-term immunosuppression in LT recipients

Topics:

• • Agenda1_0409_080507.pdf
  • Adult Living Donor Liver Transplantation Who & How.ts
  • Case 1 Decompensated Cirrhotic with COVID.ts
  • Immunosuppression Minimization Tolerance.ts
  • Medical Management of Alcoholic Liver Disease.ts
  • Panel Question & Answers 1.ts
  • Panel Question & Answers 2.ts
  • Prevention & Management of COVID-19 in Liver Disease Patients.ts
  • Readiness for Change in AUD and Behavioral Approaches.ts